Parameters in the guidelines . | Parameters in the survey . | Eight parameters . | Relative weight in eight-parameter algorithm (%) . | Five objective parameters . | Relative weight in five-parameter algorithm (%) . |
---|---|---|---|---|---|
Risk of hypoglycemia from treatment | Risk of hypoglycemia from treatment | 22.5 | Risk of hypoglycemia from treatment | 29.7 | |
Life expectancy | Life expectancy | Life expectancy | 20.5 | Life expectancy | 27.0 |
Risk potentially associated with hypoglycemia | Risk potentially associated with hypoglycemia | ||||
Important comorbidities | Important comorbidities | Important comorbidities | 13.3 | Important comorbidities | 17.5 |
Macrovascular and advanced microvascular complications | Established macrovascular complications | Macrovascular and advanced microvascular complications | 11.9 | Macrovascular and advanced microvascular complications | 15.7 |
Established microvascular complications | |||||
Cognitive function | Cognitive function | 10.3 | |||
Functional attitude and adherence | Adherence to therapy | Adherence and motivation | 7.9 | ||
Functional attitude | |||||
Disease duration | Disease duration | Disease duration | 7.6 | Disease duration | 10.0 |
Resources and support system | Resources and support system | Resources and support system | 5.9 |
Parameters in the guidelines . | Parameters in the survey . | Eight parameters . | Relative weight in eight-parameter algorithm (%) . | Five objective parameters . | Relative weight in five-parameter algorithm (%) . |
---|---|---|---|---|---|
Risk of hypoglycemia from treatment | Risk of hypoglycemia from treatment | 22.5 | Risk of hypoglycemia from treatment | 29.7 | |
Life expectancy | Life expectancy | Life expectancy | 20.5 | Life expectancy | 27.0 |
Risk potentially associated with hypoglycemia | Risk potentially associated with hypoglycemia | ||||
Important comorbidities | Important comorbidities | Important comorbidities | 13.3 | Important comorbidities | 17.5 |
Macrovascular and advanced microvascular complications | Established macrovascular complications | Macrovascular and advanced microvascular complications | 11.9 | Macrovascular and advanced microvascular complications | 15.7 |
Established microvascular complications | |||||
Cognitive function | Cognitive function | 10.3 | |||
Functional attitude and adherence | Adherence to therapy | Adherence and motivation | 7.9 | ||
Functional attitude | |||||
Disease duration | Disease duration | Disease duration | 7.6 | Disease duration | 10.0 |
Resources and support system | Resources and support system | Resources and support system | 5.9 |